BEIJING - US pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the ...

More than 20 visitors from renowned universities and research institutions worldwide gathered in Beijing on Sunday for the ...

The visit of Dr. Muhammad Yunus, the chief adviser of the interim government of Bangladesh, to China from March 26 to 29 is ...

1. AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing.

The new centre will focus on early-stage research and clinical development, supported by data science and AI labs.